Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins

Molecular Cancer Therapeutics

Volumn 4, Issue 1, 2005, Pages 61-69

  Danam, Rebecca P ^a   Howell, Sherie R ^a   Brent, Thomas P ^a   Harris, Linda C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HISTONE; HISTONE H3; HISTONE H4; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TRICHOSTATIN A; AZACITIDINE; DNA BINDING PROTEIN; HYDROXAMIC ACID; PROTEIN SYNTHESIS INHIBITOR;

ACETYLATION; ARTICLE; CELL CULTURE; CELL STRAIN HT29; CHROMATIN; CONTROLLED STUDY; DNA FLANKING REGION; DNA METHYLATION; DNA REPAIR; EPIGENETICS; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAJI CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; CELL LINE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

ACETYLATION; AZACITIDINE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; HELA CELLS; HISTONES; HUMANS; HYDROXAMIC ACIDS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS (GENETICS); PROTEIN SYNTHESIS INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 13944267211     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. 6 -alkylguanine by alkyltransferases. Mutat Res 2000;462:83-100.
2. Brent TP, Houghton PJ, Houghton JA. O 6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2- chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea. Proc Natl Acad Sci U S A 1985;82: 2985-9.
3. Harris LC, Potter PM, Tano K, Shiota S, Mitra S, Brent TP. Characterization of the promoter region of the human O 6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res 1991;19:6163-7.
4. 6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing. Mol Carcinog 1999;24: 85-9.
5. Herfarth KK, Brent TP, Danam RP, et al. A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol Carcinog 1999;24: 90-8.
6. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793-7.
7. Watts GS, Pieper RO, Costello JF, Pang YM, Dalton WS, Futscher BW. Methylation of discrete regions of the O 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol 1997;17:5612-9.
8. 6-methylguanine-DNA methyltransferase gene. Cancer Res 1997;57:3672-7.
9. Comb M, Goodman HM. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 1990;18:3975-82.
10. Bednarik DP, Ducket C, Kim SU, et al. DNA CpG methylation inhibits binding of NF-κB proteins to the HIV-1 long terminal repeat cognate DNA motifs. New Biol 1991;3:969-76.
11. Bird AP, Wolffe AP. Methylation-induced repression: belts, braces, and chromatin. Cell 1999;99:451-4.
12. Hendrich B, Bird A. Identification and characterization of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998;18:6538-47.
13. Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998;393:386-9.
14. Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998;19: 187-91.
15. Prokhortchouk E, Hendrich B. Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs? Oncogene 2002;21: 5394-9.
16. Hendrich B, Hardeland U, Ng HH, Jiricny J, Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 1999;401:301-4.
17. Prokhortchouk A, Hendrich B, Jorgensen H, et al. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev 2001;15:1613-8.
18. Richon VM, Sandhoff TW, Rifkind RA, Marks PA. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci U S A 2000;97:10014-9.
19. 6- methylguanine-DNA methyltransferase promoter: correlation with gene suppression. Carcinogenesis 1995; 16:1385-90.
20. Wade PA. Methyl CpG binding proteins: coupling chromatin architecture to gene regulation. Oncogene 2001;20:3166-73.
21. Kaufman PD, Kobayashi R, Kessler N, Stillman B. The p150 and p60 subunits of chromatin assembly factor I: a molecular link between newly synthesized histones and DNA replication. Cell 1995;81:1105-14.
22. Ridgway P, Almouzni G. CAF-1 and the inheritance of chromatin states: at the crossroads of DNA replication and repair. J Cell Sci 2000; 113:2647-58.
23. 6- methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Carcinogenesis 2003;24:1337-45.
24. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997;389:349-52.
25. Marks PA, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 2001;1:194-202.
26. Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu Rev Biochem 2001;70:81-120.
27. Cameron EE, Bachman KE, Myohanen S, et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-7.
28. Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE. Synergistic activation of functional estrogen receptor (ER)-α by DNA methyltransferase and histone deacetylase inhibition in human ER-α-negative breast cancer cells. Cancer Res 2001; 61:7025-9.
29. Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002;31:141-9.
30. Nan X, Meehan RR, Bird A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res 1993; 21:4886-92.
31. Wakefield RI, Smith BO, Nan X, et al. The solution structure of the domain from MeCP2 that binds to methylated DNA. J Mol Biol 1999; 291:1055-65.
32. Fujita N, Shimotake N, Ohki I, Chiba T, et al. Mechanism of transcriptional regulation by methyl-CpG binding protein MBDI. Mol Cell Biol 2000;20:5107-18.
33. Reese BE, Bachman KE, Baylin SB, Rountree MR. The methyl-CpG binding protein MBD1 interacts with the p150 subunit of chromatin assembly factor I. Mol Cell Biol 2003;23:3226-36.
34. Nakagawachi T, Soejima H, Urano T, et al. Silencing effect of CpG island hypermethylation and histone modifications on O 6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene 2003;22:8835-44.
35. Kondo Y, Shen LL, Issa, J-PJ. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 2003; 23:206-15.
36. Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 2003;278:4035-40.
37. Murzina N, Verreault A, Laue E, Stillman B. Heterochromatin dynamics in mouse cells: interaction between chromatin assembly factor 1 and HP1 proteins. Mol Cell 1999;4:529-40.
38. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001;410:116-20.
39. Costello JF, Futscher BW, Kroes RA, Pieper RO. Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O 6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol Cell Biol 1994; 14:6515-21.
40. 6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning. Mol Cell Biol 1997;17:5813-22.
41. Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000;343:1350-4.
42. 6-methylguanine DNA methyltransferase in human cancer. Oncogene 2004;23:1-8.